AllerGen investigator joins Board of Directors of Clinical Trials Ontario

Dr. Anne Ellis, a Kingston-based allergy specialist and an AllerGen Principal Investigator, has been appointed to the Board of Directors of Clinical Trials Ontario for a three-year term.

Established in 2012, Clinical Trials Ontario is an independent not-for-profit organization dedicated to attracting global clinical trials investments to the province. The organization aims to improve the speed and reduce costs of multi-centre clinical trials by streamlining the research ethics approval process, harmonizing administrative processes, and improving participant recruitment and retention through education about the benefits of clinical trials.

Dr. Ellis is Associate Professor and Chair, Division of Allergy & Immunology, Department of Medicine, Queen’s University and Principal Investigator of AllerGen’s Clinical Investigator Collaborative—Allergic Rhinitis.